Mr. Love will present a historical overview of U.S. and global trade agreements, highlighting policies that have been implemented and decisions that have been made to protect the pharmaceutical industry. He will provide an interpretation of current global agreements, such as the World Trade Organization's TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement and specific national pharmaceutical legislation, and will outline solutions for achieving global access to drugs. He will provide a model for global trade regimes that addresses the issue of funding research and development on essential medical technologies, while addressing concerns about access to medicines. Mr. Love will also address the issue of intellectual property rights, and what can be done to achieve drug availability and affordability in developing countries.
Learning Objectives: 1)Articulate the impact that pharmaceutical legislation and global trade agreements have had on the health of the world's poor. 2)Assess what can be done to achieve drug availability and affordability in developing countries.
Keywords: International Health, Public Health Advocacy
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.